Free Trial

Checkpoint Therapeutics (CKPT) SEC Filings & 10K Form

Checkpoint Therapeutics logo
$3.51
+0.07 (+2.03%)
(As of 11/1/2024 ET)

Recent Checkpoint Therapeutics SEC Filings

DateFilerForm TypeView
09/02/2024
11:15 PM
Checkpoint Therapeutics (Filer)
Form EFFECT
08/19/2024
4:14 PM
Checkpoint Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2024
3:40 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:45 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:05 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM
Checkpoint Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/03/2024
7:39 AM
Checkpoint Therapeutics (Filer)
Form 424B5
07/03/2024
7:44 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
7:00 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:01 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:46 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
8:00 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
8:01 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:05 PM
Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/24/2024
3:06 PM
Checkpoint Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/17/2024
4:13 PM
Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
Form SC 13D/A
05/16/2024
6:33 PM
Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:34 PM
Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:35 PM
Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:30 PM
Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:31 PM
Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:32 PM
Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
6:30 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:45 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2024
11:15 PM
Checkpoint Therapeutics (Filer)
Form EFFECT
04/02/2024
5:00 AM
Checkpoint Therapeutics (Filer)
Form DEF 14A
04/02/2024
5:03 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
03/29/2024
4:03 PM
Checkpoint Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/22/2024
5:23 PM
Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
5:24 PM
Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
Form SC 13D/A
03/22/2024
4:19 PM
Checkpoint Therapeutics (Filer)
Form PRE 14A
03/22/2024
4:13 PM
Checkpoint Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
7:52 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:00 PM
Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/01/2024
7:30 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:31 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
Form SC 13G/A
02/05/2024
4:00 PM
Checkpoint Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/02/2024
7:15 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:05 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/02/2024
7:10 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…
02/02/2024
4:15 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
4:00 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:01 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
6:10 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2023
11:15 PM
Checkpoint Therapeutics (Filer)
Form EFFECT
11/13/2023
4:15 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
4:10 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CKPT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners